Reducing Packaging Costs for Prefilled Syringes
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines.
Reducing Packaging Costs for Prefilled Syringes
Blow-fill-seal (BFS) technology presents an economical option for single-unit dose delivery of vaccines. Currently used for over-the-counter products, prescription medicines, and more than 50 injectable products, the authors present the case for using BFS for prefilled syringes. Factors including drug formulation, material compatibility, extractables and leachables, sterilization, and regulatory approval must be considered.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
About the authors
Beth Totin is chief commercial officer, and Marcus Webb is director of communications, both with ApiJect Systems, Corp.
Article Details
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 54–59
Citation
When referring to this article, please cite it as B. Totin and M. Webb, “Reducing Packaging Costs for Prefilled Syringes," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
